{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:01:28Z","timestamp":1788447688940,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd010628","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000}}],"reference-count":220,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010628.pub2","type":"journal-article","created":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T15:32:55Z","timestamp":1420126375000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Pharmacological interventions for somatoform disorders in adults"],"prefix":"10.1002","volume":"2014","author":[{"given":"Maria","family":"Kleinst\u00e4uber","sequence":"first","affiliation":[{"name":"Philipps-University Marburg; Department of Clinical Psychology and Psychotherapy; Gutenbergstr. 18 Marburg Hessen Germany D-35032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Witth\u00f6ft","sequence":"additional","affiliation":[{"name":"Johannes Gutenberg-University Mainz; Department of Clinical Psychology and Psychotherapy; Wallstr. 3 Mainz Rheinland-Pfalz Germany D-55122"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Steffanowski","sequence":"additional","affiliation":[{"name":"University of Mannheim; Department of Psychology; Schloss Ehrenhof Ost (2.OG) Mannheim Baden-W\u00fcrttemberg Germany D-68131"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm","family":"van Marwijk","sequence":"additional","affiliation":[{"name":"VU University Medical Center; Department of General Practice and Elderly Care Medicine, EMGO Institute for Health and Care Research; PO Box 7057 Amsterdam Netherlands 1007 MB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hiller","sequence":"additional","affiliation":[{"name":"Johannes Gutenberg-University Mainz; Department of Clinical Psychology and Psychotherapy; Wallstr. 3 Mainz Rheinland-Pfalz Germany D-55122"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Lambert","sequence":"additional","affiliation":[{"name":"Brigham Young University; Department of Psychology; Office TLRB 272 1001 Kimball Tower Provo Utah USA UT 84602-5543"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0001|cit1","first-page":"25","article-title":"L-sulpiride in the treatment of somatoform disturbances: a double-blind study with racemic sulpiride","volume":"32","author":"Altamura","year":"1991","journal-title":"Minerva Psichiatrica"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpain.2004.03.003","article-title":"Randomized double-blind comparison of serotonergic (citalopram) versus noradrenergic (reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder","volume":"9","author":"Aragona","year":"2005","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000118429","article-title":"A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes","volume":"19","author":"Eberhard","year":"1988","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00044011-200828040-00006","article-title":"Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial","volume":"28","author":"Han","year":"2008","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.pnpbp.2007.09.014","article-title":"Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trial","volume":"32","author":"Han","year":"2008","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YIC.0b013e328351c7e8","article-title":"Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study","volume":"27","author":"Huang","year":"2012","journal-title":"International Clinical Psychopharmacology"},{"issue":"14","key":"10.1002\/14651858.CD010628.pub2-BIB0007|cit7","first-page":"1177","article-title":"A clinical effective analysis of venlafaxine in treatment of somatoform disorders","volume":"8","author":"Jiang","year":"2005","journal-title":"Chinese General Practice"},{"issue":"10","key":"10.1002\/14651858.CD010628.pub2-BIB0008|cit8","first-page":"590","article-title":"A study of venlafaxine in the treatment of somatization disorder","volume":"15","author":"Ju","year":"2003","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"12","key":"10.1002\/14651858.CD010628.pub2-BIB0009|cit9","first-page":"733-4, 742","article-title":"Comparison study of domestic paroxetine and amitriptyline in treatment of somatoform disorders randomized double-blind study","volume":"10","author":"Kong","year":"2004","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010628.pub2-BIB0010|cit10","first-page":"S210","article-title":"Short-term treatment of depressed and anxious primary care patients with multiple, unexplained somatic symptoms: a pilot study","volume":"29","author":"Kroenke","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4088\/JCP.v67n0111","article-title":"Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder","volume":"67","author":"Kroenke","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD010628.pub2-BIB0012|cit12","first-page":"598","article-title":"Comparison study of paroxetine and paroxetine combined with quetiapine in treatment of somatoform disorder","volume":"15","author":"Li","year":"2006","journal-title":"Chinese Journal of Behavioral Medical Science"},{"issue":"8","key":"10.1002\/14651858.CD010628.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.pnpbp.2009.08.013","article-title":"A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder","volume":"33","author":"Luo","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1211\/fact.15.1.0012","article-title":"Additional benefit of Petasites hybridus (butterbur) in a four-combination for somatoform disorders","volume":"15","author":"Kraft","year":"2010","journal-title":"Focus on Alternative and Complementary Therapies"},{"issue":"5","key":"10.1002\/14651858.CD010628.pub2-BIB0017|cit15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000342466","article-title":"Results of a randomized, placebo-controlled pharmaco-clinical study with a combined herbal preparation for the treatment of patients with somatoform disorders","volume":"24","author":"Melzer","year":"2012","journal-title":"Schweizerische Zeitschrift f\u00fcr Ganzheitsmedizin"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0015|cit16","doi-asserted-by":"crossref","unstructured":"Melzer J Schrade E Brattstr\u00f6m A Schellenberg R Saller R Herbal drug combination with and without butterbur (Ze 185) for the treatment of patients with somatization disorders: randomized, placebo-controlled pharmaco-clinical trial Deutsche Gesellschaft f\u00fcr Psychiatrie, Psychotherapie und Neurologie (DGPPN) Congress; 2009 Nov 25-28; Berlin, Germany 2009","DOI":"10.1002\/ptr.2771"},{"issue":"9","key":"10.1002\/14651858.CD010628.pub2-BIB0016|cit17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ptr.2771","article-title":"Fixed herbal drug combination with and without butterbur (Ze 185) for the treatment of patients with somatoform disorders: randomized, placebo-controlled pharmaco-clinical trial","volume":"23","author":"Melzer","year":"2009","journal-title":"Phytotherapy Research"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.psy.0000128900.13711.5b","article-title":"Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial","volume":"66","author":"M\u00fcller","year":"2004","journal-title":"Psychosomatic Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/YIC.0b013e32825ea301","article-title":"Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial","volume":"23","author":"M\u00fcller","year":"2008","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD010628.pub2-BIB0020|cit20","first-page":"560","article-title":"Comparison of mirtazapine and amitriptyline in the treatment of somatoform disorders","volume":"14","author":"Ouyang","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0304-3959(90)91045-K","article-title":"A controlled study of psychotherapy and amitriptyline used individually and in combination in the treatment of chronic intractable 'psychogenic' pain","volume":"40","author":"Pilowsky","year":"1990","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S543","DOI":"10.1016\/S0924-977X(10)70817-8","article-title":"Comparison of effect of paroxetine and milnacipran for outpatients with pain disorder conference abstract","volume":"20 Suppl 3","author":"Sanada","year":"2010","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1601-5215.2003.00030.x","article-title":"Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depression","volume":"15","author":"M\u00f6ller","year":"2003","journal-title":"Acta Neuropsychiatrica"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0924-977X(00)00074-2","article-title":"Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial","volume":"10","author":"Volz","year":"2000","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0025|cit25","first-page":"3","article-title":"St. John's wort effective for somatoform disorders independent of depressive symptoms","volume":"14","author":"Anonymus","year":"2003","journal-title":"Brown University Psychopharmacology Update"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010628.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.1016\/S0924-977X(02)80536-3","article-title":"St. John's wort extract (LI 160) in somatoform disorders - results of a placebo-controlled trial","volume":"12","author":"Murck","year":"2002","journal-title":"European Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0028|cit27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-003-1420-3","article-title":"St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Erratum","volume":"167","author":"Volz","year":"2003","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0027|cit28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00213-002-1171-6","article-title":"St John's wort extract (li 160) in somatoform disorders: results of a placebo-controlled trial","volume":"164","author":"Volz","year":"2002","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0029|cit29","first-page":"70","article-title":"A double-blind study on trazodone in the treatment of persistent somatoform pain disorder","volume":"9","author":"Wang","year":"2003","journal-title":"Chinese Journal of Pain Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0030|cit30","first-page":"397","article-title":"Venlafaxine in the treatment of 35 cases of persistent somatoform pain disorder","volume":"23","author":"Xu","year":"2004","journal-title":"Herald of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0031|cit31","first-page":"262","article-title":"A control study of venlafaxine in the treatment of somatoform disorder","volume":"12","author":"Yang","year":"2006","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010628.pub2-BIB0032|cit32","first-page":"14","article-title":"Mirtazapine in treatment of somatization disorder","volume":"16","author":"Ye","year":"2006","journal-title":"Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0033|cit33","first-page":"175","article-title":"A controlled study of mirtazapine and amitriptyline in somatization","volume":"6","author":"Zhao","year":"2006","journal-title":"Evaluation and Analysis of Drug-Use in Hospitals of China"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3959(91)90007-K","article-title":"Does addition of low-dose flupenthixol enhance the analgesic effects of low-dose amitriptyline in somatoform pain disorder?","volume":"47","author":"Zitman","year":"1991","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/13651500310001833","article-title":"Levosulpiride in somatoform disorders: a double-blind, placebo-controlled cross-over study","volume":"7","author":"Altamura","year":"2003","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"19","key":"10.1002\/14651858.CD010628.pub2-BIB0036|cit36","first-page":"946","article-title":"Action of WY 3498 in hysteria and anxiety neuroses","volume":"58","author":"Ballbe","year":"1970","journal-title":"Prensa medica argentina"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0447.1967.tb05765.x","article-title":"Symptomatic relief of neurotic symptoms with tybamate: a double-blind, placebo-controlled study","volume":"43","author":"Bratfos","year":"1967","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"19","key":"10.1002\/14651858.CD010628.pub2-BIB0038|cit38","first-page":"2928","article-title":"A controlled study of the treatment of electric acupuncture and low dose perphenazine on hysteria","volume":"4","author":"Cui","year":"2004","journal-title":"Chinese Journal of the Practical Chinese with Modern Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010628.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/BF01535938","article-title":"Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study","volume":"33","author":"Davis","year":"1988","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0040|cit40","unstructured":"Farnbach P A double-blind, randomised, placebo-controlled, flexible-dose of 50 mg\/day to 400 mg\/day, phase IIIb study of the efficacy and safety of quetiapine fumarate (Seroquel XR) as an add-on therapy in patients with chronic somatoform pain disorder apps.who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12610000603011"},{"issue":"8","key":"10.1002\/14651858.CD010628.pub2-BIB0041|cit41","first-page":"1564","article-title":"Comparative evaluation of the effect on the psychosomatic symptoms between medazepam (s-804) and diazepam by means of double blind method","volume":"26","author":"Fukuda","year":"1971","journal-title":"Modern Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010628.pub2-BIB0042|cit42","first-page":"2075","article-title":"The clinical efficacy of id-540, a psychotropic drug, for psychosomatic disease and neurosis: double-blind comparative study","volume":"54","author":"Hasegawa","year":"1977","journal-title":"Rinsyotokenkyu"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0043|cit43","first-page":"129","article-title":"The suggestive action of some 'placebo' medications in the balancing of patients with somatoform disorders","volume":"39","author":"Holdevici","year":"1995","journal-title":"Revue Roumaine de Psychologie"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0044|cit44","first-page":"450","article-title":"Olanzapin in the therapy of a somatoform disorder","volume":"30","author":"Kozian","year":"2003","journal-title":"Fortbildung und Diskussion"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0045|cit45","unstructured":"Lee JH Kim B Kang EH Yu BH Anti-stress effect of Korean red ginseng (Panax ginseng C.A. Mayer) in healthy individuals with medically unexplained stress-related somatic symptoms: a randomized, double-blind, and placebo controlled clinical study. Proceedings of the 15th Pacific Rim College of Psychiatrists Scientific Meeting; 2012 Oct 25-27; Seoul, Korea 2012"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0046|cit46","unstructured":"Liu Y Liu Z Short-term deanxit in combination with sertraline treats somatic disease accompanied with depressive disorder. Study protocol (ChiCTR-TRC-11001732) www.chictr.org\/en\/proj\/show.aspx?proj=2080"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634443","article-title":"Clomipramine and mianserin in chronic idiopathic pain syndrome: a placebo controlled study","volume":"99","author":"Loldrup","year":"1989","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0447.1993.tb03439.x","article-title":"Mianserin and chronic pain: a double-blind placebo-controlled process and outcome study","volume":"88","author":"Onghena","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0028-1094479","article-title":"A comparison of the tranquilizing effect of fluspirilene and diazepam","volume":"9","author":"Pach","year":"1976","journal-title":"Pharmakopsychiatrie, Neuro-Psychopharmakologie"},{"issue":"17","key":"10.1002\/14651858.CD010628.pub2-BIB0050|cit50","first-page":"1201","article-title":"A multicentre double-blind trial of sulpiride versus toloxatone in patients with reactive depressions and somatization receiving non-specialized care","volume":"64","author":"Poinso","year":"1988","journal-title":"Semaine des hopitaux"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0051|cit51","first-page":"31","article-title":"A double-blind evaluation of fenfluramine in anxious somatizing neurotic medical clinic patients.","volume":"8","author":"Raich","year":"1966","journal-title":"Current Therapeutic Research, Clinical and Experimenta"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/009127007101100211","article-title":"A controlled comparative study of doxepin and chlordiazepoxide in psychoneurotic anxiety","volume":"11","author":"Smith","year":"1971","journal-title":"Journal of Clinical Pharmacology & New Drugs"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0053|cit53","unstructured":"Smoulevich A Tkhostov A Ivanov S Kolutskaya E A study of the efficiency of therapy of cardioneurotic patients Xth World Congress of Psychiatry, Madrid, Spain, 1996"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529609006404","article-title":"A new pharmacologic treatment of functional gastrointestinal disorder: a double-blind placebo-controlled study with mianserin","volume":"31","author":"Tanum","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD010628.pub2-BIB0055|cit55","first-page":"412","article-title":"The clinical efficacy of brotizolam (we941), a hypnotic, by the double-blind method in the field of internal medicine (psychosomatic medicine), geriatric medicine","volume":"131","author":"Tsutsui","year":"1984","journal-title":"Journal of Clinical and Experimental Medicine, Medicine in Progress"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0056|cit56","first-page":"41","article-title":"The clinical evaluation of efficacy and safety of brotizolam (we 941), a hypnotic, in the fields of internal medicine and psychosomatic medicine: A comparative study by the double-blind method","volume":"22","author":"Tsutsui","year":"1985","journal-title":"Medical Consultation & New Remedies"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0057|cit57","first-page":"1627","article-title":"The clinical evaluation of lormetazepam, a new hypnotic, in the field of internal medicine, psychosomatic medicine: a double-blind comparative study with haloxazolam","volume":"63","author":"Tsutsui","year":"1986","journal-title":"Japanese Journal of Clinical and Experimental medicine"},{"issue":"8","key":"10.1002\/14651858.CD010628.pub2-BIB0058|cit58","first-page":"3683","article-title":"Multi-center double-blind clinical trial on 450191-s, a new hypnotic, in the field of psychosomatic medicine","volume":"1","author":"Tsutsui","year":"1987","journal-title":"Clinical Report"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0059|cit59","first-page":"335","article-title":"Dose-finding study of sch161 in the field of psychosomatic medicine: double-blind comparative study with placebo","volume":"8","author":"Tsutsui","year":"1992","journal-title":"Journal of Clinical Therapeutics and Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010628.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4088\/JCP.v63n0905","article-title":"A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder","volume":"63","author":"Turkington","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"13","key":"10.1002\/14651858.CD010628.pub2-BIB0061|cit61","first-page":"2302","article-title":"A comparative study of paroxetine versus acupuncture-therapy in treatment of somatization disorder","volume":"13","author":"Xu","year":"2006","journal-title":"Journal of Practical Medical Techniques"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0062|cit62","first-page":"77","article-title":"A self body double blind clinical study of L-tryptophan and placebo in treated neurosis","volume":"24","author":"Zang","year":"1991","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0063|cit63","first-page":"256","article-title":"A self-body double-blind trial of L-tryptophan in neurosis and depression","volume":"10","author":"Zhao","year":"1989","journal-title":"Acta Academiae Medicinae Hubei"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3959(90)91089-2","article-title":"Low-dose amitriptyline in chronic pain: the gain is modest","volume":"42","author":"Zitman","year":"1990","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpsychores.2013.06.024","article-title":"Pharmacological treatment of multi-organ bodily distress syndrome: a double-blind, placebo-controlled trial of the effects of imipramine (STreSS-3)","volume":"75","author":"Agger","year":"2013","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0068|cit66","unstructured":"Fink PK Treatment of multi-organ bodily distress syndrome. A double-blinded placebo controlled trial of the effect of imipramine (STreSS-3) - Stress-3. Study protocol apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2011-004294-87-DK"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0066|cit67","unstructured":"Fink PK Agger JL Imipramine treatment for patients with multi-organ bodily distress syndrome (STreSS-3). Study protocol clinicaltrials.gov\/show\/NCT01518634"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0067|cit68","unstructured":"Fink PK Agger JL Imipramine treatment for patients with multi-organ bodily distress syndrome. Study protocol www.controlled-trials.com\/mrct\/trial\/2272077\/"},{"issue":"6","key":"10.1002\/14651858.CD010628.pub2-BIB0069|cit69","first-page":"393","article-title":"Psychosocial treatments for multiple unexplained physical symptoms: a review of literature","volume":"64","author":"Allen","year":"2002","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0071|cit71","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0072|cit72","volume-title":"Diagnostic and Statistical Manual for Mental Disorders (DSM IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0073|cit73","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual for Mental Disorders (DSM-IV-TR). 4th edition, text revision","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0074|cit74","article-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM III).","volume-title":"Diagnostic and Statistical Manual of Mental Disorders. Fifth edition. DSM-5","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0075|cit75","first-page":"337","article-title":"Psychopharmacological agents in the treatment of pain","volume":"67A","author":"Atkinson","year":"1985","journal-title":"Journal of Bone and Joint Surgery - American Volume"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0076|cit76","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften Guideline for the treatment of patients with non-specific, functional and somatoform physical complaints AWMF 2012"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1192\/bjp.157.3.404","article-title":"Hypochondriasis and somatosensory amplification","volume":"157","author":"Barsky","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archpsyc.62.8.903","article-title":"Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity","volume":"62","author":"Barsky","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0080|cit80","volume-title":"Beck Anxiety Inventory Manual","author":"Beck","year":"1990"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0081|cit81","first-page":"217","article-title":"The evaluation of therapeutic outcomes","volume-title":"Handbook of Psychotherapy and Behavior Change","author":"Bergin","year":"1971"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1572-0241.2002.05545.x","article-title":"Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study","volume":"97","author":"Bonaz","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00023210-200317080-00001","article-title":"Mechanism of action of St John's wort in depression - what is known?","volume":"17","author":"Butterweck","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0084|cit84","volume-title":"The Chinese Classification and Diagnostic Criteria of Mental Disorders Version 3 (CCMD-3)","author":"Chinese Society of Psychiatry","year":"2001"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4088\/JCP.v66n0916","article-title":"Gender differences in clinical psychopharmacology","volume":"66","author":"Clayton","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0086|cit86","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511977862.002","article-title":"Epidemiology: prevalence, causes and consequences","volume-title":"Medically Unexplained Symptoms, Somatisation and Bodily Distress","author":"Creed","year":"2011"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.184.6.470","article-title":"Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders","volume":"184","author":"Waal","year":"2004","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0088|cit88","first-page":"163","article-title":"Antipsychotic agents in the treatment of somatoform disorders: a review","volume":"53","author":"Decoutere","year":"2011","journal-title":"Tijdschrift voor Psychiatrie"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0089|cit89","volume-title":"The SCL-90-R Manual. Scoring and Administration Procedures for the SCL-90-R","author":"Derogatis","year":"1983"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0090|cit90","volume-title":"The Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual II","author":"Derogatis","year":"1992"},{"issue":"6","key":"10.1002\/14651858.CD010628.pub2-BIB0091|cit91","first-page":"S110","article-title":"Pharmacological treatment of fibromyalgia","volume":"28","author":"Franco","year":"2010","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","article-title":"Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders","volume":"125","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archpsyc.1987.01800200039006","article-title":"Somatization in the community","volume":"44","author":"Escobar","year":"1987","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0094|cit94","first-page":"589","article-title":"Pharmacological treatment of somatization\/hypochondriasis","volume":"32","author":"Escobar","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-3999(03)00631-7","article-title":"Pharmacotherapy of somatoform disorders","volume":"56","author":"Fallon","year":"2004","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpsychores.2010.02.004","article-title":"One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders","volume":"68","author":"Fink","year":"2010","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0097|cit97","unstructured":"Fink PK Treatment of multi-organ bodily distress syndrome. A double-blinded placebo controlled trial of the effect of imipramine (STreSS-3) - Stress-3. Study protocol apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2011-004294-87-DK"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0098|cit98","unstructured":"Fink PK Agger JL Imipramine treatment for patients with multi-organ bodily distress syndrome (Stress-3). Study protocol clinicaltrials.gov\/show\/NCT01518634"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0099|cit99","unstructured":"Fink PK Agger JL Imipramine treatment for patients with multi-organ bodily distress syndrome. Study protocol www.controlled-trials.com\/mrct\/trial\/2272077\/"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006842-199807000-00019","article-title":"Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis","volume":"60","author":"Fishbain","year":"1998","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00406-005-0625-3","article-title":"DSM-IV pain disorder in the general population - an exploration of the structure and threshold of medically unexplained pain symptoms","volume":"256","author":"Fr\u00f6hlich","year":"2006","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4-6","key":"10.1002\/14651858.CD010628.pub2-BIB0105|cit105","first-page":"157","article-title":"Management of chronic pain","volume":"47","author":"Gildenberg","year":"1984","journal-title":"Applied Neurophysiology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1994.tb00273.x","article-title":"Influence of antidepressants on whole gut and orocecal transit times in health and irritable-bowel-syndrome","volume":"8","author":"Gorard","year":"1994","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1176\/appi.psy.44.4.304","article-title":"Specific somatoform disorder in the general population","volume":"44","author":"Grabe","year":"2003","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1002\/14651858.CD010628.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1592\/phco.24.6.621.34748","article-title":"Treatment of pain syndromes with venlafaxine","volume":"24","author":"Grothe","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3940(02)00160-X","article-title":"Gabapentin potentiates N-methyl-D-aspartate receptor mediated currents in rat GABAergic dorsal horn neurons","volume":"324","author":"Gu","year":"2002","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3999(03)00623-8","article-title":"What can we learn from a cross-national study of somatic distress?","volume":"56","author":"Gureje","year":"2004","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0111|cit111","first-page":"218","article-title":"Clinical Global Impressions","volume-title":"ECDEU Assessment Manual for Psychopharmacology, Revised","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0113|cit113","first-page":"50","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics","volume":"163","author":"Heres","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0116|cit116","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane.org"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0117|cit117","unstructured":"Higgins JPT Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"12","key":"10.1002\/14651858.CD010628.pub2-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006524.pub2","article-title":"Consultation letters for medically unexplained physical symptoms in primary care","author":"Hoedeman","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003017.pub3","article-title":"Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood","author":"Huertas-Ceballos","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2008.944","article-title":"Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis","volume":"301","author":"H\u00e4user","year":"2009","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0121|cit121","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005332.pub2","article-title":"Pharmacotherapy and psychotherapy for body dysmorphic disorder","author":"Ipser","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","article-title":"Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis","volume":"108","author":"Jackson","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1017\/S1092852900014383","article-title":"Antidepressants and cognitive-behavioral therapy for symptom syndromes","volume":"11","author":"Jackson","year":"2006","journal-title":"CNS Spectrums"},{"issue":"7","key":"10.1002\/14651858.CD010628.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1525-1497.2006.00514.x","article-title":"Managing somatization: medically unexplained should not mean medically ignored","volume":"21","author":"Jackson","year":"2006","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S0033291703001399","article-title":"Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS)","volume":"34","author":"Jacobi","year":"2004","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0010-440X(96)90034-6","article-title":"CD-10 Checklists - a tool for clinicians' use of the ICD-10 classification of mental and behavioral disorders","volume":"37","author":"Janca","year":"1996","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0127|cit127","volume-title":"Patients with Chronic Pain. A Clinical, Clinical-pharmacological and Biochemical Study [medical dissertation]","author":"Johansson","year":"1982"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0079-6123(08)63824-8","article-title":"Descending noradrenergic influences on pain","volume":"88","author":"Jones","year":"1991","journal-title":"Progress in Brain Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0039-6109(05)70381-9","article-title":"Measurement of pain","volume":"79","author":"Katz","year":"1999","journal-title":"Surgical Clinics of North America"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0130|cit130","volume-title":"Somatization and Hypochondriasis","author":"Kellner","year":"1986"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0131|cit131","first-page":"420","article-title":"Somatoform disorders","volume-title":"Adult Psychopathology and Diagnosis","author":"Kirmayer","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cpr.2010.09.001","article-title":"Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis","volume":"31","author":"Kleinst\u00e4uber","year":"2011","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archpsyc.1997.01830160080011","article-title":"Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care","volume":"54","author":"Kroenke","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosomatic Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010628.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/PSY.0b013e31815b00c4","article-title":"Efficacy of treatment for somatoform disorders: a review of randomized controlled trials","volume":"69","author":"Kroenke","year":"2007","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","article-title":"Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma\/interleukin-10 production ratio","volume":"21","author":"Kubera","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/0022-006X.54.1.54","article-title":"Zung, Beck, and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison","volume":"54","author":"Lambert","year":"1986","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0138|cit138","first-page":"72","article-title":"Assessing psychotherapy outcomes and process","volume-title":"Handbook of Psychotherapy and Behavior Change","author":"Lambert","year":"1994"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpsychores.2006.08.009","article-title":"Course and predictors of medically unexplained pain symptoms in the general population","volume":"62","author":"Leiknes","year":"2007","journal-title":"Journal of Psychosomatic Research"},{"issue":"7400","key":"10.1002\/14651858.CD010628.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000209290","article-title":"St. John's wort - an overview","volume":"16","author":"Linde","year":"2009","journal-title":"Forschende Komplement\u00e4rmedizin"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archpsyc.1969.01740210072009","article-title":"Factors of symptom distress. Doctor ratings of anxious neurotic outpatients","volume":"21","author":"Lipman","year":"1969","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD010628.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1526-4610.2004.04121.x","article-title":"Off-label prescribing of drugs in specialty headache practice","volume":"44","author":"Loder","year":"2004","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0144|cit144","first-page":"30","article-title":"Antidepressants as analgesics: a review of randomized controlled trials","volume":"26","author":"Lynch","year":"2001","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","article-title":"Major depression and activation of the inflammatory response system","volume":"461","author":"Maes","year":"1999","journal-title":"Cytokines, Stress, and Depression"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hup.191","article-title":"The immunoregulatory effects of antidepressants","volume":"16","author":"Maes","year":"2001","journal-title":"Human Psychopharmacology - Clinical and Experimental"},{"issue":"5","key":"10.1002\/14651858.CD010628.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2165\/00003495-199142050-00002","article-title":"The use of antidepressants in the treatment of chronic pain: a review of the current evidence","volume":"42","author":"Magni","year":"1991","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/157015909790031201","article-title":"Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise","volume":"7","author":"Marks","year":"2009","journal-title":"Current Neuropharmacology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.psy.0000238213.04984.b0","article-title":"Features of hypochondriasis and illness worry in the general population in Germany","volume":"68","author":"Martin","year":"2006","journal-title":"Psychosomatic Medicine"},{"issue":"7012","key":"10.1002\/14651858.CD010628.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"Mcquay","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0152|cit152","first-page":"75","article-title":"Prevalence of DSM-IV psychiatric disorders including nicotine dependence in the general population: results from the Northern German TACOS study","volume":"9","author":"Meyer","year":"2001","journal-title":"Neurology Psychiatry and Brain Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2288-1-2","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials","volume":"1","author":"Moher","year":"2001","journal-title":"BMC Medical Research Methodology"},{"issue":"7","key":"10.1002\/14651858.CD010628.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejpain.2004.07.012","article-title":"Altered processing of pain-related information in patients with fibromyalgia","volume":"9","author":"Montoya","year":"2005","journal-title":"European Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010628.pub2-BIB0158|cit158","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1192\/bjp.158.3.379","article-title":"The Bradford Somatic Inventory - a multiethnic inventory of somatic symptoms reported by anxious and depressed patients in Britain and the Indo-Pakistan subcontinent","volume":"158","author":"Mumford","year":"1991","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.41.4.505","article-title":"Evidence for two distinct perceptual alterations in irritable bowel syndrome","volume":"41","author":"Naliboff","year":"1997","journal-title":"Gut"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3999(01)00223-9","article-title":"Medically unexplained symptoms: an epidemiological study in seven specialities","volume":"51","author":"Nimnuan","year":"2001","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s004820050125","article-title":"What is certain in pain therapy? The analgesic potency of neuroleptics in the treatment of chronic pain. A meta-analysis","volume":"12","author":"Nix","year":"1998","journal-title":"Schmerz"},{"issue":"12","key":"10.1002\/14651858.CD010628.pub2-BIB0163|cit163","first-page":"980","article-title":"Antidepressant therapy for unexplained medical symptoms and syndromes","volume":"48","author":"O'Malley","year":"1999","journal-title":"Journal of Family Practice"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1525-1497.2000.06279.x","article-title":"Treatment of fibromyalgia with antidepressants: a meta-analysis","volume":"15","author":"O'Malley","year":"2000","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/14656560902988510","article-title":"Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants","volume":"10","author":"Pae","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejpain.2004.09.001","article-title":"Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls","volume":"9","author":"Petzke","year":"2005","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1192\/bjp.113.494.89","article-title":"Dimensions of hypochondriasis","volume":"113","author":"Pilowsky","year":"1967","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ebmh.3.3.84","article-title":"Review: antidepressants are effective for clinical unexplained symptoms and syndromes","volume":"3","author":"Price","year":"2000","journal-title":"Evidence Based Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/09540261.2012.732043","article-title":"Somatic symptom disorders and illness behaviour: current perspectives","volume":"25","author":"Prior","year":"2013","journal-title":"International Review of Psychiatry"},{"issue":"7372","key":"10.1002\/14651858.CD010628.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/bmj.325.7372.1082","article-title":"Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?","volume":"325","author":"Raine","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0171|cit171","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1749-6632.1990.tb16906.x","article-title":"Serotonin and nociception","volume":"600","author":"Richardson","year":"1990","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0173|cit173","first-page":"373","article-title":"Evaluating drug treatments of generalized anxiety disorder and adjustment disorders with anxious mood","volume-title":"Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines","author":"Rickels","year":"1994"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1037\/0021-843X.107.4.587","article-title":"Cognitive aspects of hypochondriasis and the somatization syndrome","volume":"107","author":"Rief","year":"1998","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-3999(99)00023-9","article-title":"Toward empirically based criteria for the classification of somatoform disorders","volume":"46","author":"Rief","year":"1999","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-3999(02)00401-4","article-title":"A new approach to assess illness behaviour","volume":"54","author":"Rief","year":"2003","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.psyneuen.2005.03.018","article-title":"Psychobiological perspectives on somatoform disorders","volume":"30","author":"Rief","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cpr.2007.07.005","article-title":"Explaining medically unexplained physical symptoms - models and mechanisms","volume":"27","author":"Rief","year":"2007","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0179|cit179","volume-title":"SOMS Screening for Somatoform Disorders [SOMS Das Screening f\u00fcr Somatoforme St\u00f6rungen. Manual zum Fragebogen]","author":"Rief","year":"2008"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2009.01.029","article-title":"Meta-analysis of the placebo response in antidepressant trials","volume":"118","author":"Rief","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0181|cit181","volume-title":"Psychiatric Disorders in America: The Epidemiological Catchment Area Study","author":"Robins","year":"1991"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0182|cit182","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005331.pub2","article-title":"Psychosocial interventions for conversion disorder","author":"Ruddy","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1037\/0021-843X.117.2.300","article-title":"The cultural shaping of depression: somatic symptoms in China, psychological symptoms in North America?","volume":"117","author":"Ryder","year":"2008","journal-title":"Journal of Abnormal Psychology"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005454.pub2","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0185|cit185","first-page":"10","article-title":"The use of tricyclic antidepressants for the treatment of intractable pain","volume":"16","author":"Satterthwaite","year":"1990","journal-title":"Comprehensive Therapy"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(99)00107-0","article-title":"The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency","volume":"64","author":"Schreiber","year":"1999","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0187|cit187","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0188|cit188","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004844.pub2","article-title":"Antipsychotics for acute and chronic pain in adults","author":"Seidel","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/09540261.2012.746649","article-title":"Behavioural and psychological management of somatic symptom disorders: an overview","volume":"25","author":"Sharma","year":"2013","journal-title":"International Review of Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oso\/9780192624994.003.0001","article-title":"Concepts, theories and terminology","volume-title":"Treatment of Functional Somatic Symptoms","author":"Sharpe","year":"1995"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0191|cit191","volume-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0192|cit192","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1526-4610.2002.02126.x","article-title":"Olanzapine in the treatment of refractory migraine and chronic daily headache","volume":"42","author":"Silberstein","year":"2002","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD010628.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/09540261.2012.729758","article-title":"Psychopharmacotherapy of somatic symptoms disorders. Review","volume":"25","author":"Somashekar","year":"2013","journal-title":"International Review of Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0195|cit195","first-page":"274","article-title":"Placebo-controlled double-blind study examining the effectiveness of an Hypericum preparation in 105 patients with depressions","volume":"12","author":"Sommer","year":"1993","journal-title":"Nervenheilkunde"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4088\/JCP.v63n0501","article-title":"The psychopharmacology of painful physical symptoms in depression","volume":"63","author":"Stahl","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0197|cit197","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting bias. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0198|cit198","first-page":"498","article-title":"Off-label applications for SSRIs","volume":"68","author":"Stone","year":"2003","journal-title":"American Family Physician"},{"issue":"2","key":"10.1002\/14651858.CD010628.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0963721412439298","article-title":"Understanding the physical-symptom experience: the distinctive contributions of anxiety and depression","volume":"21","author":"Suls","year":"2012","journal-title":"Current Directions in Psychological Science"},{"issue":"9","key":"10.1002\/14651858.CD010628.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/PSY.0b013e31815b5cf6","article-title":"What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies","volume":"69","author":"Sumathipala","year":"2007","journal-title":"Psychosomatic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010628.pub2-BIB0201|cit201","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006520.pub2","article-title":"Psychotherapies for hypochondriasis","author":"Thomson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/jpet.104.081778","article-title":"Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action","volume":"31","author":"Urban","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1207\/s15327558ijbm0402_1","article-title":"Sensitization, somatization, and subjective health complaints","volume":"4","author":"Ursin","year":"1997","journal-title":"International Journal of Behavioral Medicine"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0204|cit204","volume-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2000"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2165\/0003495-200868180-00007","article-title":"Antidepressants for the treatment of chronic pain","volume":"68","author":"Verdu","year":"2008","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/fampra\/cml016","article-title":"Persistent presentation of medically unexplained symptoms in general practice","volume":"23","author":"Verhaak","year":"2006","journal-title":"Family Practice"},{"issue":"3","key":"10.1002\/14651858.CD010628.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-003-1420-3","article-title":"St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Erratum","volume":"167","author":"Volz","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36) .1. Conceptual-framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(98)08320-2","article-title":"Functional somatic syndromes: one or many?","volume":"354","author":"Wessely","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2002.32392","article-title":"Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?","volume":"122","author":"Whitehead","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0211|cit211","volume-title":"International Classification of Diseases. 9th revision (ICD-9)","author":"World Health Organization","year":"1975"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0212|cit212","volume-title":"International Statistical Classification of Diseases. 10th Revision (ICD-10)","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00005053-198207000-00005","article-title":"Idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder","volume":"170","author":"Williams","year":"1982","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02190261","article-title":"Lifetime and 6-month prevalence of mental disorders in the Munich follow-up-study","volume":"241","author":"Wittchen","year":"1992","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.euroneuro.2005.04.012","article-title":"Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies","volume":"15","author":"Wittchen","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.clinpsy.121208.131505","article-title":"Psychological approaches to origins and treatments of somatoform disorders","volume":"6","author":"Witth\u00f6ft","year":"2010","journal-title":"Annual Review of Clinical Psychology"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/bmj.321.7260.536","article-title":"Comparison of St John's wort and imipramine for treating depression: randomised controlled trial","volume":"321","author":"Woelk","year":"2000","journal-title":"BMJ"},{"issue":"1-2","key":"10.1002\/14651858.CD010628.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","article-title":"Endotoxin produces a depressive-like episode in rats","volume":"711","author":"Yirmiya","year":"1996","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD010628.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2006.12.009","article-title":"Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes","volume":"36","author":"Yunus","year":"2007","journal-title":"Seminars in Arthritis and Rheumatism"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010628.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T23:51:41Z","timestamp":1713397901000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010628.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":220,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010628.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]}}}